SIA
CVS icon

Soltis Investment Advisors’s CVS Health CVS Stock Holding History

Soltis Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Sell
6,619
-1,613
-20% -$144K 0.04% 302
2026
Q1 		$591K Buy
8,232
+188
+2% +$14.5K 0.04% 308
2025
Q4 		$638K Buy
8,044
+2,836
+54% +$224K 0.04% 282
2025
Q3 		$393K Buy
5,208
+396
+8% +$27.1K 0.03% 336
2025
Q2 		$332K Buy
4,812
+496
+11% +$32.5K 0.03% 308
2025
Q1 		$292K Buy
+4,316
New +$258K 0.03% 308
2024
Q4 		– Sell
-100,789
Closed -$6.34M – 377
2024
Q3 		$6.34M Buy
100,789
+1,342
+1% +$78.3K 0.62% 44
2024
Q2 		$5.87M Buy
99,447
+2,394
+2% +$150K 0.62% 45
2024
Q1 		$7.74M Buy
97,053
+5,798
+6% +$443K 0.87% 24
2023
Q4 		$7.21M Sell
91,255
-4,787
-5% -$341K 0.81% 25
2023
Q3 		$6.71M Buy
96,042
+11,033
+13% +$782K 0.86% 21
2023
Q2 		$5.88M Buy
85,009
+23,983
+39% +$1.71M 0.68% 37
2023
Q1 		$4.53M Buy
61,026
+10,822
+22% +$907K 0.58% 48
2022
Q4 		$4.68M Sell
50,204
-18,654
-27% -$1.8M 0.62% 43
2022
Q3 		$6.57M Buy
68,858
+9,897
+17% +$980K 0.99% 22
2022
Q2 		$5.46M Buy
58,961
+8,284
+16% +$808K 0.79% 29
2022
Q1 		$5.13M Buy
50,677
+20,202
+66% +$2.12M 0.71% 28
2021
Q4 		$3.14M Buy
30,475
+2,468
+9% +$228K 0.44% 44
2021
Q3 		$2.38M Buy
28,007
+1,636
+6% +$137K 0.37% 56
2021
Q2 		$2.2M Buy
26,371
+2,493
+10% +$204K 0.35% 60
2021
Q1 		$1.8M Buy
23,878
+3,465
+17% +$252K 0.33% 61
2020
Q4 		$1.39M Buy
20,413
+4,945
+32% +$322K 0.26% 71
2020
Q3 		$903K Buy
15,468
+3,889
+34% +$242K 0.21% 86
2020
Q2 		$752K Buy
11,579
+3,583
+45% +$226K 0.2% 84
2020
Q1 		$474K Buy
7,996
+2,916
+57% +$195K 0.15% 79
2019
Q4 		$377K Buy
+5,080
New +$357K 0.07% 106

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Soltis Investment Advisors's CVS Position: Q2 2026 in Review

Soltis Investment Advisors reduced its CVS Health (CVS) stake by 20% in Q2 2026, selling an estimated $144K and leaving 6,619 shares worth $685K. The position accounts for 0.04% of the portfolio, ranked #302.

Soltis Investment Advisors first reported a position in CVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $7.74M in Q1 2024. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Soltis Investment Advisors held 6,619 shares of CVS Health worth $685K as of Q2 2026.
  • Soltis Investment Advisors sold 1,613 CVS Health shares in Q2 2026, an estimated $144K.
  • CVS Health made up 0.04% of Soltis Investment Advisors's portfolio in Q2 2026, its #302 holding.
  • Soltis Investment Advisors first reported a position in CVS Health in Q4 2019 and has held it in 26 quarters since.
  • Soltis Investment Advisors's CVS Health position peaked at $7.74M in Q1 2024.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.